Senseonics Holdings, Inc.
SENS
Rank in Stocks
#11899
Senseonics Holdings, Inc. operates as a medical technology enterprise,... Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
Share Price
$9.80
Last synced: 2026-11-09
Market Cap
$518.17M
Change (1 day)
14.09%
Change (1 year)
48.71%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Senseonics Holdings, Inc. (SENS)
Category
Healthcare
Operating Margin for Senseonics Holdings, Inc. (SENS)
Operating Margin as of November 2026 TTM: -223.22%
According to Senseonics Holdings, Inc.'s latest financial reports, its current operating margin (TTM) is -223.22%. At the end of 2025 the company had an operating margin of -193.83%.
Operating Margin history for Senseonics Holdings, Inc. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -223.22% | 15.16% |
| 2025 | -193.83% | -41.80% |
| 2024 | -333.05% | -1.37% |
| 2023 | -337.66% | -19.36% |
| 2022 | -418.74% | 0.14% |
| 2021 | -418.15% | -73.85% |
| 2020 | -1,598.91% | 160.66% |
| 2019 | -613.41% | 32.47% |
| 2018 | -463.06% | -47.60% |
| 2017 | -883.62% | -93.09% |
| 2016 | -12,781.02% | -83.14% |
| 2015 | -75,821.05% | 0.00% |
| 2014 | 0.00% | -100.00% |
| 2013 | -110,523.53% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.07% |
US
|
|
| 18.08% | -100.08% |
IE
|
|
| 21.25% | -100.10% |
US
|
|
| 21.05% | -100.09% |
US
|
|
| 28.09% | -100.13% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Senseonics Holdings, Inc.'s operating margin
What is Senseonics Holdings, Inc.'s operating margin?
Senseonics Holdings, Inc.'s operating margin is -223.22%, as of Nov 2026.
What was Senseonics Holdings, Inc.'s operating margin in 2025?
In 2025, Senseonics Holdings, Inc.'s operating margin was -193.83%, compared with -333.05% in 2024.
How has Senseonics Holdings, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Senseonics Holdings, Inc.'s operating margin was highest in 2025 (-193.83%) and lowest in 2020 (-1,598.91%).
How does Senseonics Holdings, Inc.'s operating margin compare with similar companies?
Senseonics Holdings, Inc.'s operating margin (-223.22%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.